Vedanta Granted U.S. Patent
News Aug 25, 2016
Vedanta Biosciences has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 9,415,079. The patent broadly covers pharmaceutical compositions and mixtures of Clostridium live bacterial strains and builds on Vedanta’s patent issuances in Japan. The issued patent is exclusively licensed worldwide to Vedanta under an agreement with the University of Tokyo and provides coverage through at least 2031.
The patented technology is based on ground-breaking work by Dr. Kenya Honda, a scientific co-founder of Vedanta. Dr. Honda’s work provides an avenue for the treatment of a variety of diseases including immune and infectious diseases employing bacterial strains belonging to Clostridium clusters IV and/or XIVa. Clostridium bacteria include a variety of spore-forming species that can abundantly colonize the gut.
“We believe this issuance puts Vedanta in an IP leadership position in the microbiome field,” said Bernat Olle, Ph.D., Chief Executive Officer of Vedanta. “The patent has broad, fundamental claims that we believe will be important for the commercialization of microbiome therapeutics based on bacterial consortia. We intend to continue to build value from our IP estate through our internal programs as well as alliances with pharmaceutical partners.”
Strong Immune Response Linked to Stunted Growth in ChildrenNews
An overactive immune system during childhood among young people in Ecuador’s indigenous Shuar population comes with a cost: stunted growth.READ MORE
Flavins Keep a Handy Helper in Their PocketNews
A team has now shown in detail how oxygen interacts with the flavin in an enzyme - revealing for the first time precisely how it works. Flavins play a key role in metabolic processes, in the immune system and in neural development in humans - and are equally important to bacteria, fungi and plants.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018